ACB Anti-Doping player hearings - background
Since the Australian Cricket Board (ACB) and the Australian Sports Drug Agency (ASDA) began drug testing cricketers in 1998, two players have been suspended by the ACB's Anti-Doping Committee.
Australian Cricket Board
11-Feb-2003
Since the Australian Cricket Board (ACB) and the Australian Sports Drug Agency (ASDA) began drug testing cricketers in 1998, two players have been suspended by the ACB's Anti-Doping Committee.
Graeme Rummans - March 2002
The ACB Anti-Doping Committee fined then-New South Wales (NSW) player Graeme Rummans $2000 and suspended him from all forms of cricket for one month in March 2002 after he tested positive for probenecid, in December 2001.
The ACB Anti-Doping Committee fined then-New South Wales (NSW) player Graeme Rummans $2000 and suspended him from all forms of cricket for one month in March 2002 after he tested positive for probenecid, in December 2001.
Rummans had taken the substance to treat a boil on his shoulder. He was tested as part of the ACB's independent, random and unannounced drug testing program before a NSW Blues training session.
The prescribed two-year ban for a doping offence was reduced to one month after the Committee accounted for the mitigating circumstances surrounding the administration of the drug.
In handing down the penalty, the Committee also took into consideration expert testimony from ACB Anti-Doping Medical Advisor Dr Peter Harcourt on the likely effect of the substance on Rummans given the relatively low levels found in his system.
Duncan Spencer - April 2001
Western Australian player Duncan Spencer was suspended by the Australian Cricket Board (ACB) Anti-Doping Committee on 19 April 2001, after testing positive to the banned anabolic steroid, Nandrolone.
Western Australian player Duncan Spencer was suspended by the Australian Cricket Board (ACB) Anti-Doping Committee on 19 April 2001, after testing positive to the banned anabolic steroid, Nandrolone.
Spencer was suspended from playing international and interstate cricket for 18 months after admitting to taking the banned substance to aid his recovery from a back injury that had kept him out of representative cricket since 1994.
He was tested as part of the ACB's independent, random and unannounced drug testing program following the Mercantile Mutual Cup Final between Western Australia and New South Wales on 25 February 2001, and played no representative cricket after the test result was recorded.
The prescribed penalty of two years was reduced to 18 months under a discretionary power given to the Committee under the Anti-Doping Policy to consider evidence from the ACB Anti-Doping Medical Advisor, Dr Peter Harcourt.